Found 90 matching trials
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection PHASE3 To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma PHASE2 Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Show More Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer PHASE3 The purpose of this study is to estimate overall survival of Sintilimab+ ox...
Show More Location
The Fifth Medical Center,Chinese PLA General Hospital
Learn More & Join Trial
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer PHASE2 This study is a single-center, randomized controlled, phase II clinical tri...
Show More Location
Multiple Locations
Learn More & Join Trial
Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer PHASE2 To evaluate the efficacy and safety of Anlotinib Hydrochloride in Combinati...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients PHASE1 This pilot phase I trial aims to investigate the safety and tolerability of...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis PHASE1 The proposed study is an open-label, single-center, single arm phase 1b stu...
Show More Location
Beijing Tsinghua Changgung Hospital
Learn More & Join Trial
Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study PHASE2 The RADIANCE trial plans to enroll patients with chemotherapy-ineligible de...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer EARLY_PHASE1 The purpose of this study is to test the the efficacy and safety of sintili...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ) PHASE3 This is a Phase 3, prospective, randomized, open-label, multi-center study ...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial